Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seeing Red: Towards Improving 'Recognition, Documentation and Outcome 'Measurement of Incontinence-associated 'Dermatitis and Intertrigo

NCT05760469 is registered in ClinicalTrials.gov with Scotiaderm as lead sponsor.

NCT NCT05760469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05760469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seeing Red: Towards Improving 'Recognition, Documentation and Outcome 'Measurement of Incontinence-associated 'Dermatitis and Intertrigo
Lead sponsor
Scotiaderm
Phase
Not applicable
Overall status
Unknown status
Start date
May 31, 2024
Completion date
September 30, 2024
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

incontinence-associated dermatitis, intertrigo, moisture associated skin damage